Search

Your search keyword '"Teixeira, Mauro M."' showing total 562 results

Search Constraints

Start Over You searched for: Author "Teixeira, Mauro M." Remove constraint Author: "Teixeira, Mauro M." Search Limiters Peer Reviewed Remove constraint Search Limiters: Peer Reviewed
562 results on '"Teixeira, Mauro M."'

Search Results

1. Angiotensin-(1–7) decreases inflammation and lung damage caused by betacoronavirus infection in mice

2. Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial

4. Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of antiviral pharmacodynamic studies: an individual patient data meta-analysis of a randomised, controlled, adaptive platform study (PLATCOV)

6. Estimating the potential risk of transmission of arboviruses in the Americas and Europe: a modelling study

7. Antiviral efficacy of molnupiravir versus ritonavir-boosted nirmatrelvir in patients with early symptomatic COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial

8. Neuromuscular defects after infection with a beta coronavirus in mice

10. Effects of a pro‐resolving drug in COVID‐19: preclinical studies to a randomized, placebo‐controlled, phase Ib/IIa trial in hospitalized patients.

11. EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil

12. PAF signaling plays a role in obesity-induced adipose tissue remodeling

13. Relevance of angiotensin-(1-7) and its receptor Mas in pneumonia caused by influenza virus and post-influenza pneumococcal infection

15. E3 Ubiquitin Ligase Smurf1 Regulates the Inflammatory Response in Macrophages and Attenuates Hepatic Damage during Betacoronavirus Infection.

16. Natural product pharmacology: the British Journal of Pharmacology perspective.

21. Gut Dysbiosis during Influenza Contributes to Pulmonary Pneumococcal Superinfection through Altered Short-Chain Fatty Acid Production

22. Association Between Zika Virus Microcephaly in Newborns With the rs3775291 Variant in Toll-Like Receptor 3 and rs1799964 Variant at Tumor Necrosis Factor-α Gene

24. In-depth characterization of congenital Zika syndrome in immunocompetent mice: Antibody-dependent enhancement and an antiviral peptide therapy

27. Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review.

31. Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1

35. Evaluating the effects of refined carbohydrate and fat diets with acute ethanol consumption using a mouse model of alcoholic liver injury

36. Therapeutic treatment of Zika virus infection using a brain-penetrating antiviral peptide

42. Antibacterial and Antiviral Properties of Chenopodin-Derived Synthetic Peptides.

43. Secondary Streptococcus pneumoniae infection increases morbidity and mortality during murine cryptococcosis.

44. Influence of previous Zika virus infection on acute dengue episode.

49. Activities of 2-phthalimidethanol and 2-phthalimidethyl nitrate, phthalimide analogs devoid of the glutarimide moiety, in experimental models of inflammatory pain and edema

Catalog

Books, media, physical & digital resources